Management of type 2 diabetes: new and future developments in treatment
- 25 June 2011
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 378 (9786), 182-197
- https://doi.org/10.1016/s0140-6736(11)60207-9
Abstract
No abstract availableKeywords
Funding Information
- Novartis
- National Institute for Health and Care Research
- Roche
- Novo Nordisk UK Research Foundation
- Sanofi
- Novo Nordisk
- EMD Serono
- Servier
- GlaxoSmithKline
- Merck Sharp and Dohme
- Eli Lilly and Company
- AstraZeneca
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Takeda Pharmaceutical Company
This publication has 119 references indexed in Scilit:
- Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trialThe Lancet, 2010
- Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trialThe Lancet, 2010
- Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetesNature, 2010
- IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK ratProceedings of the National Academy of Sciences of the United States of America, 2009
- Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority studyThe Lancet, 2008
- The Use of Exenatide in Islet Transplant Recipients with Chronic Allograft Dysfunction: Safety, Efficacy, and Metabolic EffectsTransplantation, 2008
- Increases in morbid obesity in the USA: 2000–2005Public Health, 2007
- Small-molecule agonists for the glucagon-like peptide 1 receptorProceedings of the National Academy of Sciences of the United States of America, 2007
- A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db / db miceProceedings of the National Academy of Sciences of the United States of America, 2007
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006